Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $6.14 billion. The enterprise value is $6.08 billion.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 60.98 million shares outstanding. The number of shares has increased by 9.74% in one year.
| Current Share Class | 60.98M |
| Shares Outstanding | 60.98M |
| Shares Change (YoY) | +9.74% |
| Shares Change (QoQ) | +17.24% |
| Owned by Insiders (%) | 1.35% |
| Owned by Institutions (%) | 100.09% |
| Float | 52.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.78 |
| Forward PS | 8.79 |
| PB Ratio | 25.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 1.34.
| Current Ratio | 2.09 |
| Quick Ratio | 1.90 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.21 |
Financial Efficiency
Return on equity (ROE) is -335.82% and return on invested capital (ROIC) is -8.41%.
| Return on Equity (ROE) | -335.82% |
| Return on Assets (ROA) | -5.94% |
| Return on Invested Capital (ROIC) | -8.41% |
| Return on Capital Employed (ROCE) | -12.15% |
| Weighted Average Cost of Capital (WACC) | 6.92% |
| Revenue Per Employee | $1.36M |
| Profits Per Employee | -$1.91M |
| Employee Count | 418 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 4.42 |
Taxes
In the past 12 months, MIRM has paid $1.38 million in taxes.
| Income Tax | 1.38M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +122.03% in the last 52 weeks. The beta is 0.52, so MIRM's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +122.03% |
| 50-Day Moving Average | 96.39 |
| 200-Day Moving Average | 83.31 |
| Relative Strength Index (RSI) | 50.92 |
| Average Volume (20 Days) | 1,281,907 |
Short Selling Information
The latest short interest is 8.41 million, so 13.80% of the outstanding shares have been sold short.
| Short Interest | 8.41M |
| Short Previous Month | 8.21M |
| Short % of Shares Out | 13.80% |
| Short % of Float | 16.03% |
| Short Ratio (days to cover) | 11.48 |
Income Statement
In the last 12 months, MIRM had revenue of $569.61 million and -$798.84 million in losses. Loss per share was -$15.17.
| Revenue | 569.61M |
| Gross Profit | 463.58M |
| Operating Income | -75.12M |
| Pretax Income | -797.46M |
| Net Income | -798.84M |
| EBITDA | -50.05M |
| EBIT | -75.12M |
| Loss Per Share | -$15.17 |
Full Income StatementBalance Sheet
The company has $386.26 million in cash and $323.78 million in debt, with a net cash position of $62.48 million or $1.02 per share.
| Cash & Cash Equivalents | 386.26M |
| Total Debt | 323.78M |
| Net Cash | 62.48M |
| Net Cash Per Share | $1.02 |
| Equity (Book Value) | 242.49M |
| Book Value Per Share | 3.98 |
| Working Capital | 296.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$170.98 million and capital expenditures -$1.58 million, giving a free cash flow of -$172.55 million.
| Operating Cash Flow | -170.98M |
| Capital Expenditures | -1.58M |
| Depreciation & Amortization | 25.07M |
| Net Borrowing | n/a |
| Free Cash Flow | -172.55M |
| FCF Per Share | -$2.83 |
Full Cash Flow StatementMargins
Gross margin is 81.39%, with operating and profit margins of -13.19% and -140.24%.
| Gross Margin | 81.39% |
| Operating Margin | -13.19% |
| Pretax Margin | -140.00% |
| Profit Margin | -140.24% |
| EBITDA Margin | -8.79% |
| EBIT Margin | -13.19% |
| FCF Margin | n/a |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.74% |
| Shareholder Yield | -9.74% |
| Earnings Yield | -13.01% |
| FCF Yield | -2.81% |
Analyst Forecast
The average price target for MIRM is $144.15, which is 43.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $144.15 |
| Price Target Difference | 43.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 20.47% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 1.82 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.82 |
| Piotroski F-Score | 3 |
